Towa Pharmaceutical
4553.T
C$28.77
Share price
-1.61%
Change (1 day)
16.34%
Change (1 year)
Categories
Revenue for Towa Pharmaceutical (4553.T)
Revenue in 2024 (TTM): C$2.08 Billion
According to Towa Pharmaceutical's latest financial reports the company's current revenue (TTM 
) is C$2.12 Billion. In 2023 the company made a revenue of C$2.22 Billion an increase over the revenue in the year 2022 that were of C$1.83 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Towa Pharmaceutical from 2009 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 (TTM) | C$2.08 B | -6.18% |
| 2023 | C$2.22 B | 21.03% |
| 2022 | C$1.83 B | -2.33% |
| 2021 | C$1.88 B | 10.57% |
| 2020 | C$1.70 B | 27.69% |
| 2019 | C$1.33 B | 6.45% |
| 2018 | C$1.25 B | 21.96% |
| 2017 | C$1.02 B | -2.3% |
| 2016 | C$1.05 B | 14.78% |
| 2015 | C$0.91 B | 23.52% |
| 2014 | C$0.74 B | 17.57% |
| 2013 | C$0.63 B | -4.36% |
| 2012 | C$0.65 B | 5.91% |
| 2011 | C$0.62 B | 22.81% |
| 2010 | C$0.50 B | 17.67% |
| 2009 | C$0.43 B |